首页> 外文期刊>Circulation journal >Optimal timing of left ventricular assist device implantation for severe heart failure patients: - Focus on end-organ function not hemodynamics
【24h】

Optimal timing of left ventricular assist device implantation for severe heart failure patients: - Focus on end-organ function not hemodynamics

机译:严重心力衰竭患者左心室辅助装置植入的最佳时机:-着眼于终末器官功能而非血液动力学

获取原文
获取原文并翻译 | 示例
           

摘要

In this issue of the Journal, Yoshioka et al present their results of left ventricular assist device (LVAD) implantation and a retrospective analysis for determining the pre-operative factors for 90-day mortality, comprising 3 independent analyses. Firstly, the authors divided all patients into 2 groups according to the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile: level 1 (n=41) and level 2/3 (n=43). Naturally, preoperative laboratory variables reflecting infection and multi-organ function were worse in the level 1 group than in level 2/3. The postoperative comorbidities were also more frequent in the level 1 group. Secondly, they focused on the preoperative predictor for 90-day mortality.
机译:在本期《华尔街日报》上,Yoshioka等人介绍了他们的左心室辅助装置(LVAD)植入的结果以及用于确定90天死亡率的术前因素的回顾性分析,包括3项独立分析。首先,作者根据机构间机械辅助循环支持(INTERMACS)档案将所有患者分为两组:1级(n = 41)和2/3级(n = 43)。自然地,在1级组中反映感染和多器官功能的术前实验室变量比2/3级更差。 1级组的术后合并症也更常见。其次,他们集中于90天死亡率的术前预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号